Review article: drug interactions with agents used to treat acid-related diseases (Q33734848)

29 July 2017

1 reference

title

Review article: drug interactions with agents used to treat acid-related diseases (English)

1 reference

29 July 2017

1 reference

T J Humphries

1

1 reference

29 July 2017

G J Merritt

series ordinal

2

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

Alimentary Pharmacology & Therapeutics

29 July 2017

published in

1 reference

29 July 2017

volume

13 Suppl 3

1 reference

29 July 2017

page(s)

18-26

1 reference

Pathogenesis and treatment of acid peptic disorders: comparison of proton pump inhibitors with other antiulcer agents

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Symposium on geriatrics--Part I: Drug prescribing for elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Polypharmacy in the aged. Practical solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Drug interactions and clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Measurement and analysis of unbound drug concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Influence of oral contraceptives on drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Loss of analgesic effect of morphine due to coadministration of rifampin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Clinical pharmacology of omeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Metabolic interactions of the proton-pump inhibitors lansoprazole, omeprazole and pantoprazole with other drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Clinical relevance of cimetidine drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Pharmacokinetic interactions of cimetidine 1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Incidence and cost of hospital admissions secondary to drug interactions involving theophylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Procainamide-cimetidine drug interaction in elderly male patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Increased toxicity and reduced clearance of lidocaine by cimetidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Effect of cimetidine and ranitidine on cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Interactions and Non-Interactions with Ranitidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Minor effect of multiple dose omeprazole on the pharmacokinetics of digoxin after a single oral dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Digitalis. An update of clinical pharmacokinetics, therapeutic monitoring techniques and treatment recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Influence of gastric acidity on the bioavailability of digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Clinical Pharmacokinetics of Lansoprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Comparison of the interaction potential of a new proton pump inhibitor, E3810, versus omeprazole with diazepam in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Pharmacokinetic drug interactions of macrolides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Cisapride. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Drug interactions with antacids. Mechanisms and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Drug-antacid interactions: assessment of clinical importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

Effects of antacids on the clinical pharmacokinetics of drugs. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2036.1999.00021.X

10.1046/J.1365-2036.1999.00021.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference